Status:
COMPLETED
Management of Nausea and Vomiting Chemotherapy-induced in Normandy
Lead Sponsor:
Centre Francois Baclesse
Conditions:
Cancer
Nausea
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study was to evaluate the various parameters involved in the occurrence of nausea / vomiting during the first cycle of chemotherapy for solid tumors or hematologic among a group ...
Eligibility Criteria
Inclusion
- Aged over 18 years
- With solid tumors or hematologic in first line chemotherapy, administered intravenously,
- Able to understand the meaning of the questions
- Having given their written consent to participate in the survey.
Exclusion
- This does not concern patients who:
- Do not give their consent for participation
- Do not speak French
- Suffer from cognitive deficits
- Are under therapy
- Must receive a combination of radio-chemotherapy
- Present an occlusive syndrome
- Metastases (s) brain (s) clinically symptomatic (s) or radiologically proven (s) or a (of) tumor (s) brain (s)
- Have been previously treated with chemotherapy
- Present a cons-indication to corticosteroids, with anti-serotonin or NK1 receptor inhibitors
- Pregnant or breastfeeding.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01440465
Start Date
July 1 2011
End Date
February 1 2013
Last Update
December 17 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de la Baie
Avranches, France, 50307
2
Centre hospitalier
Bayeux, France, 14400
3
Centre Maurice Tubiana
Caen, France, 14052
4
Centre François Baclesse
Caen, France, 14076